- Clinical Trials
- April 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- April 2024
- 106 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- February 2025
- 247 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- May 2024
- 128 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- May 2024
- 130 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Drug Pipelines
- April 2024
- 80 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- November 2023
- 30 Pages
Global
From €2625EUR$2,750USD£2,199GBP
- Report
- January 2022
- 200 Pages
Global
From €7158EUR$7,500USD£5,997GBP
- Report
- January 2022
- 60 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- January 2022
- 60 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- January 2022
- 60 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- August 2022
- 141 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- August 2022
Global
From €754EUR$790USD£632GBP
- Report
- May 2022
- 64 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- May 2022
- 41 Pages
Global
From €1909EUR$2,000USD£1,599GBP

The Spasticity Drug market is a subset of the Central Nervous System Drugs market. It is composed of drugs used to treat spasticity, a condition characterized by muscle stiffness and spasms. These drugs are used to reduce the severity of spasticity symptoms, allowing patients to regain control of their movements. Commonly used spasticity drugs include baclofen, dantrolene, and tizanidine. Botulinum toxin injections are also used to treat spasticity, as they can reduce muscle spasms and improve range of motion.
The Spasticity Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Allergan, Merz, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more